One Of Two Pfizer Lipitor Patents Upheld By U.K. Court
The company says the British court’s ruling, which could keep Ranbaxy’s generic off the market until 2011, “has no bearing” on atorvastatin patent litigation in the U.S.
The company says the British court’s ruling, which could keep Ranbaxy’s generic off the market until 2011, “has no bearing” on atorvastatin patent litigation in the U.S.